Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study

BACKGROUND: Coronavirus disease 2019 (COVID‐19) is a respiratory disease associated with thrombotic outcomes with coagulation and endothelial disorders. Based on that, several anticoagulation guidelines have been proposed. We aimed to determine whether anticoagulation therapy modifies the risk of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Chocron, Richard, Galand, Vincent, Cellier, Joffrey, Gendron, Nicolas, Pommier, Thibaut, Bory, Olivier, Khider, Lina, Trimaille, Antonin, Goudot, Guillaume, Weizman, Orianne, Alsac, Jean Marc, Geneste, Laura, Schmeltz, Armand, Panagides, Vassili, Philippe, Aurélien, Marsou, Wassima, Ben Abdallah, Iannis, Deney, Antoine, El Batti, Salma, Attou, Sabir, Juvin, Philippe, Delmotte, Thomas, Messas, Emmanuel, Pezel, Théo, Planquette, Benjamin, Duceau, Baptiste, Gaussem, Pascale, Sutter, Willy, Sanchez, Olivier, Waldman, Victor, Diehl, Jean‐Luc, Mirault, Tristan, Bonnet, Guillaume, Cohen, Ariel, Smadja, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174166/
https://www.ncbi.nlm.nih.gov/pubmed/33550816
http://dx.doi.org/10.1161/JAHA.120.018624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174166/
https://www.ncbi.nlm.nih.gov/pubmed/33550816
http://dx.doi.org/10.1161/JAHA.120.018624

Ejemplares similares